Home
Conditions
Stage IIIC Skin Melanoma

Clinical trial condition

Stage IIIC Skin Melanoma

Explore clinical trials studying Stage IIIC Skin Melanoma. Study availability and eligibility vary by location and protocol.

17 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IIIC Skin Melanoma trial results

Completed

Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma

NCT03028948

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +21 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

NCT03154190

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
Locations: Virginia K Crosson Cancer Center Fullerton, California, United States

View Trial Details

Completed

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

NCT03229278

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy

NCT02857374

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +16 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

NCT03112668

Conditions: Breast Diseases, Breast Neoplasms, Colonic Diseases, +80 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

NCT01886235

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +19 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

NCT02320305

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +16 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases

NCT02941744

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: UZ Brussel Jette, Brabant, Belgium

View Trial Details

Completed

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

NCT01460875

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +18 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

NCT01961115

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +25 more
Locations: Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Duke University Medical Center Durham, North Carolina, United States

Cleveland Clinic Foundation Cleveland, Ohio, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Stage IIIC Skin Melanoma

Stage IIIC Skin Melanoma trial results

Related conditions